BIOVIA's End-to-End Solutions Connecting Virtual and Real
Generative AI has tremendous potential for drug discovery, but without scientific context and experimental validation, AI-generated predictions are not enough.
Combining Scientific AI with physics-based modeling and real-world experimental feedback enables researchers to design higher-quality candidates with greater confidence.
Download the e-book to learn how BIOVIA's end-to-end Small Molecule Therapeutics Design solutions help discovery teams:
- Explore larger chemical space with generative AI while leveraging NVIDIA GPU-optimized AI microservices
- Enhance designs with 3D physics-based models
- Optimize leads with lab-in-the-loop active learning cycles
- Improve collaboration across multidisciplinary teams
- Increase R&D efficiency and productivity.